Morgan Stanley Call 100 MDT 20.12.../ DE000ME5CN65 /
6/3/2024 11:43:55 AM | Chg.+0.003 | Bid1:00:18 PM | Ask1:00:18 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.067EUR | +4.69% | 0.067 Bid Size: 3,750 |
0.074 Ask Size: 3,750 |
Medtronic PLC | 100.00 USD | 12/20/2024 | Call |
GlobeNewswire
6/2
NVIDIA Enables Real-Time Healthcare, Industrial and Scientific AI Applications at the Edge With Ente...
GlobeNewswire
5/13
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
5/9
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for im...
GlobeNewswire
4/30
Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Paten...
GlobeNewswire
4/23
Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue
GlobeNewswire
4/23
Blue Cross and Blue Shield of Minnesota Announces Chris Boles as Vice President of Medicare, Melissa...
GlobeNewswire
3/27
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market G...
GlobeNewswire
3/26
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of D...
GlobeNewswire
3/13
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy ...
GlobeNewswire
3/6
Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemod...
GlobeNewswire
2/26
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambu...
GlobeNewswire
2/5
Inspire Medical Systems, Inc. Announces Chair Marilyn Carlson Nelson to Retire and Timothy P. Herber...
GlobeNewswire
1/8
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pace...
GlobeNewswire
12/29/2023
Visionary Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its ...
GlobeNewswire
11/13/2023
Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update